- Conditions
- Hydrocephalus
- Interventions
- Rhaeos Shunt Monitoring System (RSMS), ShuntCheck III
- Device
- Lead sponsor
- Rhaeos, Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Hydrocephalus
- Interventions
- Thermal Anisotropy Measurement Device
- Device
- Lead sponsor
- Rhaeos, Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Normal Pressure Hydrocephalus
- Interventions
- CereVasc eShunt System, VP Shunt
- Device
- Lead sponsor
- CereVasc Inc
- Industry
- Eligibility
- 60 Years and older
- Enrollment
- 230 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2031
- U.S. locations
- 29
- States / cities
- Los Angeles, California • New Haven, Connecticut • Jacksonville, Florida + 21 more
- Conditions
- Hydrocephalus, Normal Pressure
- Interventions
- ShuntCheck
- Diagnostic Test
- Lead sponsor
- University of South Florida
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 20 participants
- Timeline
- 2020 – 2027
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Cerebrospinal Fluid Shunts, Ventriculoperitoneal Shunt
- Interventions
- Ceftaroline
- Drug
- Lead sponsor
- Basim Asmar
- Other
- Eligibility
- 6 Months to 17 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Hydrocephalus
- Interventions
- Endoscopic Third Ventriculostomy with Choroid Plexus Cauterization (ETV+CPC), Ventriculoperitoneal Shunt
- Procedure · Device
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 1 Day to 104 Weeks
- Enrollment
- 176 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2027
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 15 more
- Conditions
- Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Embryonal Tumor, Ependymal Tumor
- Interventions
- C7R-GD2.CART cells (IV and ICV infusion)
- Genetic
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 12 Months to 25 Years
- Enrollment
- 56 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2041
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Hydrocephalus, Normal Pressure
- Interventions
- ShuntCheck
- Diagnostic Test
- Lead sponsor
- University of South Florida
- Other
- Eligibility
- 40 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2026
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Hydrocephalus
- Interventions
- Thermal Anisotropy Measurement Device
- Device
- Lead sponsor
- Rhaeos, Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 44 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 4
- States / cities
- Oakland, California • San Francisco, California • Chicago, Illinois
- Conditions
- Pseudotumor Cerebri
- Interventions
- ShuntCheck
- Diagnostic Test
- Lead sponsor
- University of South Florida
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 12 participants
- Timeline
- 2019 – 2026
- U.S. locations
- 1
- States / cities
- Tampa, Florida
- Conditions
- Hydrocephalus
- Interventions
- Ventriculoperitoneal shunt insertion surgery
- Procedure
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 1 Day to 17 Years
- Enrollment
- 448 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2020
- U.S. locations
- 11
- States / cities
- Birmingham, Alabama • Los Angeles, California • Denver, Colorado + 8 more
- Conditions
- Hydrocephalus
- Interventions
- wireless thermal anisotropy measurement device
- Device
- Lead sponsor
- Rhaeos, Inc.
- Industry
- Eligibility
- 6 Years to 80 Years
- Enrollment
- 29 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Idiopathic Intracranial Hypertension
- Interventions
- Acetazolamide, Optic Nerve Sheath Fenestration, Ventriculoperitoneal CSF Shunting
- Drug · Procedure
- Lead sponsor
- Jaeb Center for Health Research
- Other
- Eligibility
- 18 Years to 63 Years
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019
- U.S. locations
- 33
- States / cities
- Los Angeles, California • Palo Alto, California • Aurora, Colorado + 26 more
- Conditions
- Intraventricular Hemorrhage, Premature Infants
- Interventions
- NIRS, aEEG, and CSF concentration of biomarkers
- Procedure
- Lead sponsor
- University of Utah
- Other
- Eligibility
- Up to 1 Year
- Enrollment
- 63 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2015
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Hydrocephalus
- Interventions
- Not listed
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Pseudotumor Cerebri, Idiopathic Intracranial Hypertension (IIH)
- Interventions
- Dural Venous Sinus Stenting, Cerebrospinal Fluid Shunting
- Device
- Lead sponsor
- St. Joseph's Hospital and Medical Center, Phoenix
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Seattle, Washington
- Conditions
- High Grade Glioma
- Interventions
- NK cells
- Biological
- Lead sponsor
- Nationwide Children's Hospital
- Other
- Eligibility
- 12 Months to 39 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 1
- States / cities
- Columbus, Ohio
- Conditions
- Hydrocephalus
- Interventions
- Thermal Anisotropy Measurement Device
- Device
- Lead sponsor
- Rhaeos, Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 141 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 10
- States / cities
- Oakland, California • San Francisco, California • Chicago, Illinois + 5 more
- Conditions
- Hemorrhage, Premature Infants, Newborn, Hydrocephalus
- Interventions
- ETV/CPC
- Procedure
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 0 Months to 12 Months
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2026
- U.S. locations
- 3
- States / cities
- Boston, Massachusetts
- Conditions
- Communicating Hydrocephalus
- Interventions
- Endoscopic third ventriculostomy (ETV), Ventricular shunt
- Procedure
- Lead sponsor
- Duke University
- Other
- Eligibility
- 1 Year to 18 Years
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Recurrent Medulloblastoma, Recurrent Ependymoma
- Interventions
- Irinotecan, Temozolomide, Bevacizumab, Omburtamab I-131, Liothyronine, SSKI, Dexamethasone, Antipyretic, Antihistamine, anti-emetics
- Drug
- Lead sponsor
- Pediatric Brain Tumor Consortium
- Network
- Eligibility
- Up to 21 Years
- Enrollment
- 62 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 3
- States / cities
- Los Angeles, California • New York, New York • Cincinnati, Ohio
- Conditions
- Hydrocephalus
- Interventions
- Ventriculoperitoneal Shunt Placement, Endoscopic Third Ventriculostomy(ETV)
- Procedure
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 50 Years and older
- Enrollment
- 13 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Signs or Symptoms of Shunt Failure
- Interventions
- Not listed
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- Up to 18 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2007
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin
- Conditions
- Ventriculoperitoneal Shunt, Infection
- Interventions
- Not listed
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 350 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania